id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-P-1668-0010,FDA,FDA-2022-P-1668,Interim Response Letter from FDA CFSAN to Akin Gump Strauss Hauer & Feld LLP,Other,Response(s),2023-01-18T05:00:00Z,2023,1,2023-01-18T05:00:00Z,,2023-01-18T17:37:50Z,,0,0,09000064855f5fc8